Roche (RHHBY) Needs to Give FTC Extra Information in Illumina (ILMN) Bid

Roche (OTC: RHHBY)has received a request for additional information, often referred to as a “second request,” from the Federal Trade Commission (“FTC”) in connection with Roche’s proposed acquisition of Illumina, Inc. (Nasdaq: ILMN). The second request was issued pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR Act”). The second request seeks additional information regarding Roche’s microarray business.

The effect of the second request is to extend the waiting period imposed by the HSR Act until 10 days after Roche has substantially complied with the second request, unless that period is extended voluntarily by Roche or terminated sooner by the FTC.

Roche will continue to work closely and cooperatively with the FTC as it conducts its review of the proposed transaction in order to respond to and resolve expeditiously any questions the FTC may have.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Holcim to acquire Fermacell from James Hardie for EUR 840M
• Bernstein on whether Hershey (HSY) could eventually step up to buy Mondelez (MDLZ)
• T. Rowe Price to acquire F/m Investments in fixed income push